-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities: Poster II

Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 6, 2015: 6:00 PM-8:00 PM
Hall A, Level 2 (Orange County Convention Center)

Joshua A Hill, MD1,2*, Bryan T Mayer, PhD1*, Hu Xie, MSc1*, Wendy M Leisenring, PhD3*, Filippo Milano, MD, PhD3, Colleen Delaney, MD, MSc3, Meei-Li Huang, PhD4*, Terry L Stevens-Ayers, MS1*, Keith R Jerome, MD, PHD1,4*, Garrett Nichols, MD, MS5*, Danielle M Zerr, MD, MPH6*, Joshua T Schiffer, MD, MS1,2* and Michael Boeckh, MD1,2

1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA
2Department of Medicine, University of Washington, Seattle, WA
3Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
4Department of Laboratory Medicine, University of Washington, Seattle, WA
5Chimerix, Inc., Durham, NC
6Pediatric Infectious Diseases, Seattle Children's Research Institute, Seattle, WA

Florent Malard, MD, PhD1*, Myriam Labopin, MD2*, Gernot Stuhler, MD3*, Johanna Tischer, MD4*, Joerg Thomas Bittenbring, MD,5*, Arnold Ganser, M.D.6, Nicolaus Kroeger, MD7, Donald Bunjes, MD8*, Christoph Schmid, MD9, Jiri Mayer10, Mauricette Michallet, MD, PhD11, Michael Hallek, MD12, Bipin N. Savani, MD13, Mohamad Mohty, MD, PhD14 and Arnon Nagler, MD, MSc15

1Hematology Department, CHU, Nantes, France
2Department of Hematology and Cell Therapy, Saint Antoine Hospital, Paris, France
3Zentrum für Blutstammzell- und Knochenmarktransplantation, DKD Helios Klinik Wiesbaden, Wiesbaden, Germany
4Ludwig-Maximilians-University Hospital of Munich-Grosshadern, Department of Internal Medicine III, Hematopoietic Cell Transplantation, Munich, Germany
5Department of Internal Medicine I, Saarland University Medical School, Homburg, Germany
6Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
7Center of Oncology - Bone Marrow Transplantation Unit, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
8Department of Internal Medicine III, University of Ulm, Ulm, Germany
9Ludwig-Maximilians-University of Munich, Germany, Department of Hematology and Oncology, Klinikum Augsburg, Augsburg, Germany
10Department of Internal Medicine - Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
11Department of Hematology, Centre Hospitalier Lyon-Sud, Lyon, France
12Department of Internal Medicine, University of Cologne, Cologne, Germany
13Department of Medicine, Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, TN
14Hematology, Hospital Saint-Antoine, Paris University UPMC, INSERM U938, Paris, France
15Chaim Sheba Medical center and EBMT Acute Leukemia Working Party, Tel-Hashomer and Paris, Israel

Ramzi Abboud, MD1, Jesse Keller, MD2, Michael Slade, BA3*, Michael P. Rettig, PhD4, Stephanie Meier2*, John F. DiPersio, MD, PhD2, Todd A Fehniger, MD, PhD2, Kathryn Trinkaus5*, Geoffrey L. Uy, MD6, Peter Westervelt, MD, PhD7, Ravi Vij, MD2, Camille N. Abboud, MD, FACP1, Khoan Vu, M.D.8, Pavan Kumar Bhamidipati, MBBS, MD2 and Rizwan Romee, MD1

1BMT and Leukemia Program, Washington University School of Medicine, Saint Louis, MO
2Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO
3Department of Medicine, Division of Oncology, Washington University School of Medicine, St Louis, MO
4Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO
5Department of Biostatistics, Washington University School of Medicine, Saint Louis, MO
6Division of Oncology, Washington University School of Medicine, Saint Louis, MO
7Division of Oncology, Washington University School of Medicine, St. Louis, MO
8Department of Medicine, Washington University School of Medicine, Saint Louis, MO

Franco Locatelli, MD, PhD1,2, Maura Faraci, MD3*, Simone Cesaro, MD4*, Daria Pagliara, MD2*, Franca Fagioli, MD5*, Marco Zecca, MD6*, Vian Amber, MBChB, MSc, PhD, FRCPath, MFPM7*, Kamalika Banerjee, MS8*, Giorgia Finetto9*, Fabio Ciceri, MD10* and on Behalf Of The Italian Therapeutic Use Study Group9*

1University of Pavia, Pavia, Italy
2Department of Pediatric Hematology and Oncology, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy
3SCT Unit-Haematology-Oncology Department, G. Gaslini Children’s Research Institute, Genova, Italy
4Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy
5Università degli Studi di Torino, Turin, Italy
6Pediatric Hematology/Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
7Jazz Pharmaceuticals, Oxford, United Kingdom
8Jazz Pharmaceuticals, Palo Alto, CA
9Gentium S.p.A., Villa Guardia, Italy
10San Raffaele Scientific Institute, Milan, Italy

Don J. Diamond, PhD1, Corinna La Rosa, PhD1*, Jeffrey Longmate, PhD2*, Joy Martinez1*, Qiao Zhou1*, Theodora Kaltcheva, PhD1*, Jennifer Drake3*, Mary Carroll3*, Sanjeet Dadwal, MD4*, Ibrahim Aldoss, MD5, Ryotaro Nakamura, MD5 and John A. Zaia, MD6

1Department of Experimental Therapeutics, Beckman Research Institute of City of Hope, Duarte, CA
2Department of Information Sciences, City of Hope, Duarte, CA
3Clinical Trials Office, City of Hope National Medical Center, Duarte, CA
4Division of Infectious Disease, City of Hope National Medical Center, Duarte, CA
5Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
6Center for Gene Therapy, Beckman Research Institute of City of Hope, Duarte, CA

David Charles Keahi Oliver, BS1,2*, Filippo Milano, MD, PhD2, Hilary Gammill, MD1,2*, Coline Gentil, MS2*, Sami B. Kanaan, PhD2*, Judy Allen, MPH2*, Lee Nelson, MD1,2* and Colleen Delaney, MD, MSc2,3

1University of Washington School of Medicine, Seattle, WA
2Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
3Division of Pediatric Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA

Giorgia Battipaglia1,2*, Myriam Labopin, MD3,4,5*, Anna Candoni, MD6*, Renato Fanin7, Jean El Cheikh8*, Didier Blaise9, Mauricette Michallet, MD, PhD10, Annalisa Ruggeri, MD, PhD1*, Natalie Contentin11*, Josep Ribera, MD, PhD12, Michael Stadler, MD13*, Jorge Sierra, MD, PhD14, Peter A. Von Dem Borne15, Adrian Bloor, FRCPath16*, Gerard Socie17, Mohamad Mohty, MD, PhD1,3,5 and Arnon Nagler, MD, MSc5,18

1Service d’Hématologie et Thérapie Cellulaire, Hôpital Saint-Antoine, Paris, France
2Hematology Department, Federico II University, Naples, Italy
3Hospital Saint-Antoine, Paris University UPMC, INSERM U938, Paris, France
4Department of Hematology and Cell Therapy, Saint Antoine Hospital, Paris, France
5EBMT, Acute Leukemia Working Party, Paris, France
6Hematology, Santa Maria della Misericordia University Hospital, Udine, Italy
7Division of Hematology and BMT, Department of Experimental and Clinical Medical Sciences, Azienda Ospedaliero-Universitaria di Udine, Udine, Italy
8Hematology, Institut Paoli-Calmettes, Marseille, France
9Department of Hematology, Institut Paoli Calmettes, Marseille, France
10Department of Hematology, Centre Hospitalier Lyon-Sud, Lyon, France
11Hematology, Centre Becquerel, Rouen, France
12Department of Hematology, ICO Badalona-Germans Trias i Pujol Hospital. Josep Carreras Leukemia Research Institute. Universitat Autonoma de Barcelona, Badalona, Spain
13Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
14Hematology, Hospital Santa Creu i Sant Pau, Barcelona, Spain
15Department of Hematology, Leiden University Medical Center, Leiden, Netherlands
16The Christie NHS Foundation Trust, Manchester, United Kingdom
17St-Louis Hospital, Paris, France
18Division of Hematology, Sheba Medical Center, Ramat Gan, Israel

Federica Giannotti, MD1,2*, Annalisa Ruggeri, MD, PhD2,3*, Myriam Labopin, MD4,5,6*, Jan Cornelissen, MD, PhD7, Mauricette Michallet, MD, PhD8, Dimitrios Karakasis, MD, PhD9*, Eric Deconinck, MD, PhD10, Pierre-Simon Rohrlich, MD, PhD11*, Gerard Socie12, Didier Blaise13, Eefke Petersen, MD, PhD14, Pierre Feugier, MD, PhD15*, Henrik Sengeloev, MD16*, Thierry Lamy, MD, PhD17, Nigel H. Russell, MD18, Noel-Jean Milpied, MD19, Charles F. Craddock, BM, MRCP, MRCPath20,21, Chantal Kenzey, DATAMANAGER22*, Mohamad Mohty, MD, PhD2, Eliane Gluckman, MD23, Arnon Nagler, MD, MSc24,25 and Vanderson Rocha, MD, PhD26,27

1Eurocord - Monacord, Saint Louis Hospital, Paris, France
2Service d’Hématologie et Thérapie Cellulaire, Hôpital Saint-Antoine, Paris, France
3Eurocord, Hôpital Saint Louis APHP, University Paris-Diderot, Paris, France
4Hospital Saint-Antoine, Paris University UPMC, INSERM U938, Paris, France
5Department of Hematology and Cell Therapy, Saint Antoine Hospital, Paris, France
6EBMT, Acute Leukemia Working Party, Paris, France
7Department of Hematology, Erasmus MC-Daniel den Hoed Cancer Centre, Rotterdam, Netherlands
8Hematology, Hopital Edouard Herriot, Lyon, France
9Department of Hematology and Lymphomas, Evangelismos Hospital, Athens, Greece
10Hematology, INSERM UMR645 - CHU Jean Minjoz, Besançon, France
11Hematologie Clinique, CHU - Hôpital de l`ARCHET I, Nice, France
12St-Louis Hospital, Paris, France
13Department of Hematology, Institut Paoli Calmettes, Marseille, France
14University Medical Centre Utrecht, Utrecht, Netherlands
15CHU et INSERM 954, Nancy Université, Vandoeuvre Les Nancy, France
16BMT Unit Dept. of Hematology, Rigshospitalet, Copenhagen, Denmark
17Haematology, CHU Pontchaillou, Rennes, France
18Centre for Clinical Haematology, Nottingham University Hospital, Nottingham, United Kingdom
19hematology, Hopital Haut Leveque - Pessac, Pessac, France
20University Hospital Birmingham, Birmingham, United Kingdom
21Centre for Clinical Haematology, University Hospital Birmingham, Birmingham, United Kingdom
22Eurocord, Hôpital Saint Louis, Paris, France
23Eurocord-Monacord, Saint-Louis Hospital, Paris, France
24EBMT Acute Leukemia Working Party and Registry, Hematology Division, BMT and Cord Blood Bank, Tel-Aviv University, Chaim Sheba Medical Center, Tel-Hashomer, Ramat- Gan, Israel
25Sheba Medical Center, Sheba Cord Blood Bank, Tel-Hashomer, Israel
26Eurocord - Monacord, Hôpital Saint Louis, Paris, France
27Churchill Hospital, Oxford University, Oxford, United Kingdom

Tiago Nava, MD1*, Marc Ansari, MD2,3,4, Yves Theoret, PhD5,6,7*, Mohamed Aziz Rezgui5,6*, Samira Mezziani1*, Marie-France Vachon1*, Michel Duval, MD1,5,8, Henrique Bittencourt, MD, PhD1,5,8 and Maja Krajinovic, PhD5,6,7,9*

1Onco-Hematology Division, CHU Sainte-Justine, University of Montreal, Montreal, QC, Canada
2Department of Pediatrics, Onco-hematology Unit, Geneva University Hospitals, Geneva, Switzerland
3Onco-Hematology Unit, Department of Pediatrics, University of Geneva, Geneva, Switzerland
4Department of Pediatrics, CANSEARCH Research Laboratory, Faculty of Medicine, Geneva, Switzerland
5Charles-Bruneau Cancer Center, CHU Sainte-Justine Research Center, Montreal, QC, Canada
6Department of Pharmacology, Faculty of Medicine, University of Montreal, Montreal, QC, Canada
7Clinical Pharmacology Unit, CHU Sainte-Justine Research Center, Montreal, QC, Canada
8Department of Pediatrics, Faculty of Medicine, University of Montreal, Montreal, Canada
9Department of Pediatrics Onco-Hematology Division, CHU Sainte-Justine Research Center, Montreal, QC, Canada

Hirotoshi Sakaguchi, MD, PhD1*, Kimikazu Matsumoto, MD, PhD2*, Kotaro Narita, MD3*, Motoharu Hamada, MD3*, Shinsuke Kataoka, MD3*, Naoyuki Miyagawa, MD3*, Nao Yoshida, MD, PhD1*, Masafumi Ito, MD, PhD4* and Koji Kato, MD, PhD1

1Department of Hematology and Oncology, Children's Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
2Children’s Cancer Center, National Center for Child Health and Development, Tokyo, Japan
3Department of Hematology and Oncology, Children’s Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
4Department of Pathology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan

Amit Kalra, MBBS, MS1*, Cameron Roessner, BScPharm2*, Jennifer Jupp, BScPharm, BCOP3*, Andrew Daly, MD, FRCPC1 and Jan Storek, MD, PhD1

1University of Calgary, Calgary, AB, Canada
2University of Alberta, Edmonton, AB, Canada
3Foothills Medical Centre, Calgary, AB, Canada

Scott R. Solomon, MD1, Melissa Sanacore, Pharm.D.1*, Xu Zhang, PhD2*, Katelin Connor1*, Melhem Solh, MD1, Lawrence E. Morris, MD1, H. Kent Holland, MD1 and Asad Bashey, MD, PhD1

1The Blood and Marrow Transplant Program at Northside Hospital, Atlanta, GA
2Department of Mathematics and Statistics, Georgia State University, Atlanta, GA

Saurabh Zanwar, MD1*, Anant Ganesh Gokarn, MD DM2*, Santhosh Devdas, MD DM1*, Sachin Khurana, MD1*, Avinash Bonda, MD1*, Ritesh Pruthy3*, Vivek Bhat, MD4*, Sajid Qureshi5*, Tapan Saikia, MD6 and Navin Khattry, MD DM2*

1Medical Oncology, Tata Memorial Centre, Mumbai, India
2Tata Memorial Center, ACTREC, Mumbai, India
3Surgical Oncology, Tata Memorial Centre, Mumbai, India
4Microbiology, Tata Memorial Hospital, ACTREC, Navi Mumbai, India
5Surgical Oncology, Tata Memorial Center, Mumbai, India
6Dept. of Medical Oncology, Prince Aly Khan Hospital, Mumbai, India

Reed Friend, MD1, James Xenakis2*, Jonathan S Serody, MD3, Terrance Comeau, MD4, Don A. Gabriel, MD, PhD3, Stefanie Sarantopoulos, MD, PhD5, James Coghill, MD6, William A. Wood, MD, MPH3, Andrew Sharf3*, Julia S Whitley, BS7*, Kamakshi Rao, PharmD3*, Christine M Walko, PharmD, BCOP8*, Anastasia Ivanova, PhD3*, Thomas C. Shea, MD3 and Paul M Armistead, MD, PhD3*

1Leo Jenkins Cancer Center, East Carolina University, Greenville, NC
2Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC
3Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
4Saint John Regional Hospital, St. John, NB, Canada
5Duke Cancer Institute, Duke University Medical Center, Durham, NC
6Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC
7University of North Carolina School of Medicine, Chapel Hill, NC
8Moffitt Cancer Center, Tampa, FL

Amado J Karduss-Urueta, MD1, Suarez Gloria, MD1*, Gonzalez Miguel, MD1*, Perez Rosendo, MD1*, Pedro Reyes, MD1*, Alejo Jimenez, MD1*, Luis R Gomez, MD1*, Angelica M Cardona, Tech2*, Jose Betancur, MD3*, Monica Ramirez, MD3* and Giovanni Ruiz, MD1*

1Bone Marrow Transplant Program, Instituto de Cancerologia, Medellin, Colombia
2Research Unit, Instituto de Cancerologia, Medellin, Colombia
3Pediatric Critical care Unit, Clinica las Americas, Medellin, Colombia

Mita Manna, MD, FRCPC1, Andrew Daly, MD, FRCPC2, Bill Kangarloo3*, Mary Lynn Savoie, MD, FRCPC4 and Jan Storek, MD, PhD2

1Department of Medicine, University of Calgary, Calgary, AB, Canada
2University of Calgary, Calgary, AB, Canada
3University of Calgary, Calgary, Canada
4Division of Hematology and Hematologic Malignancies, University of Calgary, Calgary, AB, Canada

Ezhil Pavai Mohanan, MSc1*, John C Panetta, PhD2*, Shareen Stella Backia Royan, BSc3*, Ajay Abraham, MSc1*, Eunice Sindhuvi Edison, PhD1*, Kavitha M Lakshmi, MSc1*, Fouzia Nambiathayil Abubacker, DM3*, Anu Korula, MD, DM1*, Aby Abraham, MD, DM1*, Auro Viswabandya, MD, DM1,4, Biju George, DM1, Alok Srivastava, MD, FRACP1,5, Vikram Mathews, DM1 and Poonkuzhali Balasubramanian, Ph.D1

1Department of Haematology, Christian Medical College, Vellore, India
2Department of Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, TN
3Department of Hematology, Christian Medical College, Vellore, India
4Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada
5Christian Medical College, Centre for Stem Cell Research, Vellore, India

Nancy A. Kernan, MD1, Paul G. Richardson, MD2, Angela R. Smith, MD3, Brandon M. Triplett, MD4*, Stephan A. Grupp, MD, PhD5, Joseph H. Antin, MD6, Leslie E. Lehmann, MD7, Wei Liang, PhD8*, Robin L. Hume, MS8*, Alison L. Hannah, MD8, Bijan Nejadnik, MD8 and Robert J. Soiffer, MD9

1Pediatric BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY
2Division of Hematologic Malignancy, Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
3Division of Pediatric Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN
4Bone Marrow Transplantation and Cellular Therapy, St. Jude Children’s Research Hospital, Memphis, TN
5Pediatric Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA
6Stem Cell/Bone Marrow Transplantation Program, Division of Hematologic Malignancy, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
7Center for Stem Cell Transplantation, Division of Hematologic Malignancy, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
8Jazz Pharmaceuticals, Palo Alto, CA
9Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

Amandine Le Bourgeois1*, Florent Malard1,2,3*, Patrice Chevallier, MD, PhD4*, Thierry Guillaume, MD, PhD4*, Jacques Delaunay, MD4*, Pierre Peterlin, MD4*, Patricia Lemarchand, MD, PhD5*, Patrick Germaud, MD5*, Mohamad Mohty, MD, PhD6,7, Philippe Moreau8* and Arnaud Chambellan, MD5*

1Department of Hematology, Nantes University Hospital, Hôtel Dieu, Nantes, France
2UMR 1064-Center for Research in Transplantation and Immunology, INSERM, Nantes, France
3UMRs 938, Paris, France and Université Pierre et Marie Curie, INSERM, Nantes, France
4Department of Hematology, Nantes University Hospital, Nantes, France
5INSERM, UMR1087, l’institut du thorax, Nantes, France
6Hematology Department, Saint-Antoine Hospital, AP-HP, Universite Pierre et Marie Curie, Paris, France
7Hospital Saint-Antoine, Paris University UPMC, INSERM U938, Paris, France
8Nantes University Hospital, Hôtel‐Dieu, Nantes, France

Marina O Popova, PhD1*, Alisa G Volkova1*, Soulaiman Elias Soulaiman2*, Olga N Pinegina1*, Svetlana M Ignatyeva, PhD3*, Tatyana S Bogomolova, PhD3*, Anna G Smirnova, PhD1*, Maria D Vladovskaya, PhD1*, Sergey N Bondarenko, PhD1*, Ludmila S Zubarovskaya, Professor1*, Nikolay N Klimko, Professor1* and Boris V Afanasyev, Professor1*

1Raisa Gorbacheva Memorial Institute of Children Oncology, Hematology and Transplantation, First Pavlov State Medical University of Saint-Petersburg, Saint-Petersburg, Russia
2Hematology-transplantation department, Tishreen hospital, Damascus, Syria
3Dept. of Clinical Mycology, I. Metchnikov North-Western State Medical University, Saint-Petersburg, Russia

Raffaella Greco, MD1*, Maria Chiara Barbanti, MD2*, Nicasio Mancini, MD3*, Laura Infurnari3*, Renée Pasciuta3*, Alessandra Forcina, MD2*, Luca Vago, MD, PhD1,4, Fabio Giglio, MD2*, Carlo Messina, MD2*, Mara Morelli, MD2*, Tommaso Perini, MD2*, Stefania Girlanda, MD2*, Matteo G Carrabba, MD1*, Maria Teresa Lupo Stanghellini, MD2*, Sarah Marktel, MD2*, Andrea Assanelli, MD5*, Massimo Bernardi, MD5*, Consuelo Corti, MD2*, Jacopo Peccatori, MD2*, Massimo Clementi, MD3* and Fabio Ciceri, MD5,6*

1Unit of Hematology and Bone Marrow Transplantation, San Raffaele Scientific Institute, Milano, Italy
2Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy
3Laboratory of Microbiology and Virology, Vita-Salute San Raffaele University, San Raffaele Scientific Institute, Milan, Italy
4Unit of Immunogenetics, Leukemia Genomics and Immunobiology, San Raffaele Scientific Institute, Milano, Italy
5Hematology and Bone Marrow Transplantation Unit, San Raffaele Hospital Scientific Institute, Milan, Italy
6Vita-Salute San Raffaele University, Milan, Italy

Ren Lin1*, Zhiping Fan1*, Ke Zhao, MD1*, Qianli Jiang, MD, PhD1*, Jing Sun, MD2 and Qifa Liu, MD1

1Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
2Department of Hematology, NanFang Hospital, Southern Medical University, Guangzhou, China

*signifies non-member of ASH